Last updated: 11/03/2018 13:27:11
Meta-analysis of observational studies of Fluticasone propionate/salmeterol combination.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Control of Asthma With Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroid Regimens Systematic Review A Meta-analysis of Observational Studies
Trial description: The purpose of this study was to compare asthma related outcomes, including emergency department visits and hospitalzations. A meta-analysis of published and un-published studies that meet apriori criteria on length of study and outcomes measured for comparative trials of ICS vs ICS/LABA combination in pediatrics and ICS/LABA vs ICS/montelukast
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
asthma related emergency department or hospitalizatons
Timeframe: over at least 6 months post exposure
Secondary outcomes:
Not applicable
Interventions:
Drug: Fluticasone propionate/salmeterol combination
Drug: Inhaled corticosteroids
Enrollment:
0
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Not applicable
Medical condition
Asthma
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Not applicable
Study date(s)
September 2008 to November 2008
Type
Observational
Phase
4
Participation criteria
Sex
Female & Male
Age
Not applicable
Accepts healthy volunteers
No
- Studies that compared fluticasone propionate/salmeterol and inhaled corticosteroids in asthma, Primary, observational, non-interventional, comparative studies of retrospective or prospective design. number of patients in each study cohort, treatment protocol (i.e., medications and doses used). Evaluation of, and preferably adjustment for, differences in baseline severity between groups.
- . Reviews, meta-analyses, controlled trials, and studies published only in abstract form were excluded.
Inclusion and exclusion criteria
Inclusion criteria:
- Studies that compared fluticasone propionate/salmeterol and inhaled corticosteroids in asthma, Primary, observational, non-interventional, comparative studies of retrospective or prospective design. number of patients in each study cohort, treatment protocol (i.e., medications and doses used). Evaluation of, and preferably adjustment for, differences in baseline severity between groups.
Exclusion criteria:
- . Reviews, meta-analyses, controlled trials, and studies published only in abstract form were excluded.
Trial location(s)
No location data available.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2008-19-11
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website